Gene · 4192
Papers2,993
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,993
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Endothelium-specific sensing of mechanical signals drives epidermal aging through coordinating retinoid metabolism. | Theranostics | 2025 | 40585982 | PubTator, text mining | PubMed |
| Blocking the functional domain of cancer cell surface TIP1 upregulates Midkine via the β-catenin/Wnt signaling pathway. | Cancer Gene Ther | 2025 | 40533520 | PubTator, text mining | PubMed |
| EGFRvIII-positive glioblastoma contributes to immune escape and malignant progression via the c-Fos-MDK-LRP1 axis. | Cell Death Dis | 2025 | 40527884 | PubTator, text mining | PubMed |
| Ugonin P mitigates osteolytic bone metastasis by suppressing MDK via upregulating miR-223-3p expression. | Int J Biol Sci | 2025 | 40520001 | PubTator, text mining | PubMed |
| Primitive Hepatoblasts Driving Early Liver Development. | bioRxiv | 2025 | 40501632 | PubTator, text mining | PubMed |
| Midkine (MDK) in cancer and drug resistance: from inflammation to therapy. | Discov Oncol | 2025 | 40500394 | PubTator, text mining | PubMed |
| Dissecting the endothelial cell landscape in meningioma: single-cell insights into PLVAP+ subpopulations and their role in tumor angiogenesis. | Front Immunol | 2025 | 40496867 | PubTator, text mining | PubMed |
| Targeting the MDK/c-Myc complex to overcome temozolomide resistance in glioma. | Clin Transl Med | 2025 | 40468625 | PubTator, text mining | PubMed |
| Significance of Midkine Signaling in Women's Cancers: Novel Biomarker and Therapeutic Target. | Int J Mol Sci | 2025 | 40429950 | PubTator, text mining | PubMed |
| Integrative single-cell and spatial transcriptomics analysis reveals MDK-NCL pathway's role in shaping the immunosuppressive environment of lung adenocarcinoma. | Front Immunol | 2025 | 40396179 | PubTator, text mining | PubMed |
| Single cell transcription revealing key transcription factors in embryonic kidney development. | Mol Cell Biochem | 2025 | 40392427 | PubTator, text mining | PubMed |
| High Midkine Expression Correlates with Poor Prognosis and Immune Cell Infiltration in Hepatocellular Carcinoma. | Int J Gen Med | 2025 | 40386763 | PubTator, text mining | PubMed |
| A novel pH-sensitive nanoparticles encapsulating anti-PD-1 antibody and MDK-siRNA overcome immune checkpoint blockade resistance in HCC via reshaping immunosuppressive TME. | J Exp Clin Cancer Res | 2025 | 40380202 | PubTator, text mining | PubMed |
| Current perspectives of urine-based tests for screening and post-treatment monitoring of urothelial carcinoma of the bladder. | Transl Androl Urol | 2025 | 40376516 | PubTator, text mining | PubMed |
| Spatial mapping of innate lymphoid cells in human lymphoid tissues and lymphoma at single-cell resolution. | Nat Commun | 2025 | 40374674 | PubTator, text mining | PubMed |
| scSDNE: A semi-supervised method for inferring cell-cell interactions based on graph embedding. | PLoS Comput Biol | 2025 | 40333631 | PubTator, text mining | PubMed |
| The combination of midkine inhibitor with Lenvatinib amplifies the suppression of hepatocellular carcinoma. | IUBMB Life | 2025 | 40321061 | PubTator, text mining | PubMed |
| Prolonged fasting promotes systemic inflammation and platelet activation in humans: A medically supervised, water-only fasting and refeeding study. | Mol Metab | 2025 | 40268190 | PubTator, text mining | PubMed |
| Association between the preoperative Midkine (+)/CEA (+) level and poor prognosis in colorectal cancer patients. | Surg Today | 2025 | 40266400 | PubTator, text mining | PubMed |
| Emerging regulators of gastric cancer angiogenesis: Synergistic effects of regulator of G protein signaling 4 and midkine. | Cytojournal | 2025 | 40260064 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4192/papers?page=11